Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChAdOx1 NipahB vaccine study in adults in Bangladesh
ISRCTN62461807Phase 2Active, not recruiting
- Sponsor
- University of Oxford
- Start
- Oct 2025
- Modality
- Vaccines & Immunotherapeutics, Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ChAdOx1 NipahB in Nipah virus infection (NiV) (4 arms), sponsored by University of Oxford. Primary endpoints: Solicited local reactogenicity signs and symptoms, Solicited systemic reactogenicity signs and symptoms and 4 more. Started Oct 2025; status: active, not recruiting.
02
Drugs
ChAdOx1 NipahB
03
Conditions
Nipah virus infection (NiV)
Beyond the preview
Go deeper on ISRCTN62461807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN62461807.